期刊文献+

Vero细胞和脊髓灰质炎病毒在无血清条件下的培养探究 被引量:4

Investigation on cultivation of Vero cell and poliovirus under serum-free condition
下载PDF
导出
摘要 目的探索Vero细胞和脊髓灰质炎病毒在无血清条件下的最佳培养条件,为无血清培养Vero细胞生产脊髓灰质炎疫苗奠定基础。方法选择直接适应(直降组)和序贯适应(驯化组)两种无血清培养方法,观察Vero细胞和脊髓灰质炎病毒在无血清条件下的生长情况,并检测脊髓灰质炎病毒及其病毒滴度。结果 Vero细胞在两种无血清条件下均生长良好,其中驯化组细胞生长速度更接近对照组。以脊髓灰质炎病毒Sabin株Ⅰ型分别感染直降组、驯化组和对照组细胞的病毒滴度平均值分别为8.94、8.81和8.94 LgCCID50/mL;Ⅱ型病毒滴度平均值分别为8.84、8.25和7.94 LgCCID50/mL;Ⅲ型病毒滴度平均值分别为8.91、8.57和8.63 LgCCID50/mL;且3组的变异系数(CV)均小于10%。结论 Vero细胞在无血清条件下生长良好,无血清培养的Vero细胞可用作脊髓灰质炎疫苗生产的基质。 Objective To explore the optimal condition for serum-free cultivation of Vero cell and poliovirus.Methods Two methods were carried out for cultivation of Vero cell by using serum-free medium including a direct adaptation ( direct adaption group ) and a sequential adaptation ( acclimatization group ) .Vero cells and poliovirus were cultured and observed in serum-free conditions , and poliovirus titers were detected too .Results The growth status of Vero cell was in good con-dition cultured in the two kinds of serum free media , and the cell growth rate in acclimation group is approximatelly to reach that in control group .The mean value of virus titers were 8.94 lgCCID50/mL, 8.81 lgCCID50/mL and 8.94 lgCCID50/mL respectively in Vero cell infected with poliovirus typeⅠSabin strain for direct adaption group , acclimatization group and con-trol group.The mean value of virus titers were 8.84 lgCCID50 mL, 8.25 lgCCID50/mL and 7.94 lgCCID50/mL respectively in Vero cell infected with poliovirus typeⅡSabin strain in three groups .The mean value of virus titers was 8.91 lgC-CID50 mL, 8.57 lgCCID50/mL and 8.63 lgCCID50/mL respectively in Vero cell infected with poliovirus typeⅢSabin strain in three groups .The coefficient of variation ( CV) values for all three groups were less than 10%.Conclusion The cul-ture of Vero cell in serum-free condition is successful for the proliferation of poliovirus used as a substrate in production of vaccines .
出处 《微生物学免疫学进展》 2013年第5期18-22,共5页 Progress In Microbiology and Immunology
关键词 无血清培养 VERO细胞 脊髓灰质炎病毒 Serum-free culture Vero cell Poliovirus
  • 相关文献

参考文献9

  • 1Merten OW. Safety for vaccines [ J]. Cytotechnology, 2000,34 (3) :181-183..
  • 2Frazatti-Gallina NM, Mourao-Fuches RM, Paoli RL, et al. Vero-cell rabies vaccine produced using serum-free medium [ J ]. Vaccine, 2004,23 (4) :511-517.
  • 3Kuwae S, Ohda T, Tamashima H, et al. Development of a fed-batch culture process for enhanced production of recombinant human an- tithrombin by Chinese hamster ovary cells [J]. J Biosci Bioeng, 2005,100 (5) :502-510.
  • 4Holzer GW, Mayrhofer J, Leitner J, et al. Overexpression of Hepati tis B virus surface antigens including the preS1 region in a senlIn free Chinese hamster ovary cell line[ J]. Protein Exp Purif, 2003 29 ( 1 ) : 58-69.
  • 5Wu SC, Huang GY. Stationary and microcarrier cell culture process-ses for propagating Japanese encephalitis virus [ J ]. Bio- technol Prog,2002,18 ( 1 ) : 124-128.
  • 6Kurokawa M, Sato S. Growth and poliovirus production of Vero cells on a novel mierocarrier with artificial cell adhesive protein under serum-free conditions [ J ]. Biosc Bioeng, 2011,111 ( 5 ) : 600 -604.
  • 7何春艳,唐丽丽,李嘉,韩玉英,吴书军,周琳婷,应通锋,秦洁.非洲绿猴肾细胞(Vero)无血清细胞库的建立[J].中国生物制品学杂志,2007,20(7):482-485. 被引量:4
  • 8Cinatl JJ, Cinatl J, Rabenau H, et al. Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses[J]. Cell Biol Int, 1993,17(9) :885-895.
  • 9Merten OW, Kallel H, Manuguerra JC, et al. The new medium MDSS2N, free of any animal protein supports cell growlh and pro- duetion of various viruses [J].Cytotechnology, 1999,30 ( 1/3 ) : 191-201.

二级参考文献7

  • 1Kistner O,Barrett PN,Mundt W,et al.Development of a mammalian cell(Vero) derived candidate influenza virus vaccine.Vaccine,1998,16(9):960-968.
  • 2Frazatti-Gallina NM,Mourao-Fuches RM,Paoli RL,et al.Verocell rabies vaccine produced using serum-free medium.Vaccine,2004,23(4):511-517.
  • 3Kuwae S,Ohda T,Tamashima H,et al.Development of a fedbatch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells.J Biosci Bioeng,2005,100(5):502-510.
  • 4Holzer GW,Mayrhofer J,Loitner J,et al.Overexpression of hepatitis B virus surface antigens including the preS1 region in a senumfree Chinese hamster ovary cell line.Protein Expr Purif,2003,29(1):58-69.
  • 5Halpefin SA,Nestruck AC,Eastwoed BJ.Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture.Vaccine,1998,16(13):1331-1335.
  • 6Gevorkova EA,Murti G,Meignier B,et al.African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.J Virol,1996,70(8):5519-5524.
  • 7Wu SC,Huang GY.Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus.Biotechnol Prog,2002,18(1):124-128.

共引文献3

同被引文献74

  • 1廉红霞,高腾云,傅彤,孙宇,李改英.实时荧光定量PCR定量方法研究进展[J].江西农业学报,2010,22(10):128-129. 被引量:17
  • 2王永民,陈昭烈.动物细胞无血清培养基的研究与设计方法[J].中国生物工程杂志,2007,27(1):110-114. 被引量:15
  • 3Schroder M, Matischak K, Friedl P. Serum--and protein--free media formulations for the Chinese hamster ovary cell line DUKXBll [J].J Biootechnol, 2004, 108(3): 279-292.
  • 4Whitford WG, Fairbank A. Considerations in scale-up of viral vac- cine production [ J ]. BioProcess Int,2011,9 ( 8 ) : 16-28.
  • 5Rourou S, vall der Ark A, Majoul S,et al. A novel animal-compo- nent-free medium for rabies virus production in Vero cells grown on Cytodex 1 in a stirred bioreactor [ J]. Appl Microbiol Biotechnol, 2009, 85 ( 1 ) :53-63.
  • 6Barrett PN, Mundt W, Kistner O, et al. Vero cell platform in vaccine production: moving towards cell culture-based viral vac- cines [ J ]. Expert Rev Vaccines,2009, 8 (5) ,607-618.
  • 7吴雪伶,袁宝珠.干扰素系统的完整性与Vero细胞病毒敏感性的相关性[c]//2012年中国药学大会暨第十二届中国药师周论文集.北京:中国药学会,2012.
  • 8Jelinek T. Japanese encephalitis vaccine in travelers [ J ]. Expert Rev Vaccine,2008,7 (5) :689-693.
  • 9Govorkova EA, Murti G, Meignier B, et al. African green monkey kidney (Vero) cells provide an alternative host cell system for in- fluenza A and B viruses[J]. J Virol,1996,70(8) : 5519-5524.
  • 10Barrett PN, Portsmouth D, Ehrlich HJ. Yero cell culture-derived pandemic influenza vaccines: preclinical and clinical development[J]. Expert Rev Vaccines, 2013,12(4) :395-413.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部